The role of endocannabinoids in the hypothalamic regulation of visceral function

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 301-307

  Wenger, T ^a   Moldrich, G ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; DRUG RECEPTOR; ENDOCANNABINOID; ICOSANOID; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; LEPTIN; LUTEINIZING HORMONE; PROLACTIN; RIMONABANT;

ANIMAL; DRUG EFFECT; DRUG POTENTIATION; FOOD INTAKE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION; THERMOREGULATION; VISCERA; ADENOHYPOPHYSIS; APPETITE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; HORMONE BLOOD LEVEL; HYPERTHERMIA; HYPOTHERMIA; MOUSE; NONHUMAN; PREGNANCY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REPRODUCTION; THERMOGENESIS;

ANIMALS; APPETITE REGULATION; BODY TEMPERATURE REGULATION; CANNABINOIDS; EICOSANOIDS; ENDOCANNABINOIDS; HUMANS; HYPOTHALAMUS; PITUITARY GLAND; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VISCERA;

EID: 0036019415     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0353     Document Type: Article

References (66)

1. The hypothalamus as a major integrative center
2. Hashish in Islam 9th to 18th century
3. Effects of Δ9 tetrahydrocannabinol on pregnancy, puberty and the neuroendocrine system
4. Isolation, structure and partial synthesis of an active constituent of hashish
5. Determination and characterization of a cannabinoid receptor in the rat brain
6. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
7. Molecular aspects of cannabinoid receptors
8. Molecular characterization of a peripheral receptor for cannabinoids
9. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
10. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
11. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
12. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
13. 2 cannabinoid receptor
14. 1 receptor knockout mice
15. Localization of cannabinoid receptors in brain and periphery
16. 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
17. 1 cannabinoid receptor in the rat brain. An immunohistochemical study
18. Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: An overview
19. Effects of marihuana use on body weight and caloric intake in humans
20. Cannabinoids and appetite stimulation
21. 9-THC
22. 1) receptors
23. 9-tetrahydrocannabinol on hypothalamically induced feeding
24. 1) receptors
25. Appetite suppression and weight loss after the cannabinoid antagonists SR 141716
26. 1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset
27. Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
28. 9-tetrahydrocannabinol-tolerant rats
29. Cannabinoid transmission and reward-related events
30. Leptin-regulated endocannabinoids are involved in maintaining food intake
31. The therapeutic use of Cannabis sativa (L.) in arabic medicine
32. Effects of cannabinoids on thermoregulation: A brief review
33. Biphasic effects of anandamide
34. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
35. In vivo interactions between psychotropic cannabinoids and other drugs involving central and peripheral neurochemical
36. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
37. Anandamide, an endogenous ligand of the cannabinoid receptor, reduces hypomotility and hypothermia in vivo in rodents
38. Behavioral effects of cannabinoid agents in animals
39. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
40. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioral effects of anandamide-treated rats
41. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
42. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
43. 1 cannabinoid receptor
44. 1 cannabinoid receptors in the anterior lobe of the pituitary gland
45. 1 receptor mRNA in the pituitary gland
46. Delta-9-tetrahydrocannabinol and luteinizing hormone secretion
47. Mode of action of delta-9-tetrahydrocannabinol on the hypothalamo-pituitary function in adult female rats
48. Acute effect of intracerebro-ventricularly injected delta-9-tetrahydrocannabinol on serum LH and FSH in adult male rats
49. Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle stimulating hormone secretion in adult male rats
50. Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat
51. The effects of prenatally administered endogenous cannabinoid on rat offspring
52. The effects of cannabinoids on the regulation of reproduction
53. The endogenous cannabinoid system and brain development
54. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
55. Distribution of neuronal cannabinoid receptors in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
56. The endogenous cannabinoid, anandamide, regulates anterior pituitary secretion in vitro
57. Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation
58. 1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland
59. 1 receptor knockout mice
60. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions
61. The effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat
62. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
63. Arachydonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus
64. Functional significance of cannabinoid receptors in brain